| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
ShuYu Civilian Pharmacy Corp., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥10.33 |
| 52 Week High | CN¥22.37 |
| 52 Week Low | CN¥8.87 |
| Beta | 0.44 |
| 11 Month Change | 12.90% |
| 3 Month Change | 4.98% |
| 1 Year Change | -47.19% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -37.81% |
Recent News & Updates
Recent updates
Shareholder Returns
| 301017 | CN Consumer Retailing | CN Market | |
|---|---|---|---|
| 7D | 5.9% | 12.7% | 9.6% |
| 1Y | -47.2% | -27.9% | -12.3% |
Return vs Industry: 301017 underperformed the CN Consumer Retailing industry which returned -27.9% over the past year.
Return vs Market: 301017 underperformed the CN Market which returned -12.3% over the past year.
Price Volatility
| 301017 volatility | |
|---|---|
| 301017 Average Weekly Movement | 11.1% |
| Consumer Retailing Industry Average Movement | 5.8% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in CN Market | 8.4% |
| 10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 301017's share price has been volatile over the past 3 months.
Volatility Over Time: 301017's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 16,485 | Guangxia Qin | www.shuyupingmin.com |
ShuYu Civilian Pharmacy Corp., Ltd. operates a chain of pharmaceutical retail stores in China. It offers Chinese and Western patent medicines, health foods, Chinese herbal medicines, health equipment, and other products. The company is also involved in the pharmaceutical online store and wholesale business.
ShuYu Civilian Pharmacy Corp., Ltd. Fundamentals Summary
| 301017 fundamental statistics | |
|---|---|
| Market cap | CN¥4.16b |
| Earnings (TTM) | CN¥18.21m |
| Revenue (TTM) | CN¥9.75b |
240.2x
P/E Ratio0.4x
P/S RatioIs 301017 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301017 income statement (TTM) | |
|---|---|
| Revenue | CN¥9.75b |
| Cost of Revenue | CN¥7.15b |
| Gross Profit | CN¥2.60b |
| Other Expenses | CN¥2.58b |
| Earnings | CN¥18.21m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.045 |
| Gross Margin | 26.68% |
| Net Profit Margin | 0.19% |
| Debt/Equity Ratio | 136.3% |
How did 301017 perform over the long term?
See historical performance and comparison